Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
23.07
+1.28 (5.87%)
At close: Jul 2, 2026, 4:00 PM EDT
22.98
-0.09 (-0.39%)
After-hours: Jul 2, 2026, 7:19 PM EDT
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $3.81 billion as of July 2, 2026. Its market cap has increased by 208.95% in one year.
Market Cap
3.81B
Enterprise Value
3.01B
1-Year Change
208.95%
Ranking
Category
Stock Price
$23.07
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $3.81B, an increase of 382.21%. That is a compound annual growth rate of 31.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 3.81B | 18.42% |
| Dec 31, 2025 | 3.22B | 34.33% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 4.21B |
| Denali Therapeutics | 4.06B |
| Telix Pharmaceuticals | 4.04B |
| NewAmsterdam Pharma Company | 4.03B |
| Relay Therapeutics | 3.95B |
| Catalyst Pharmaceuticals | 3.85B |
| Structure Therapeutics | 3.77B |
| Arcus Biosciences | 3.76B |